Tracer library / [111In]DOTAGA-FAP-2286

[111In]DOTAGA-FAP-2286

Also written as [In-111]In-DOTAGA-FAP-2286
Radionuclide
In-111 t½ 4031.6 min
Modality
Therapy
Production route
—
Stage
Reported once
Syntheses indexed
0
Preclinical only, no clinical indication yetFibroblast activation / tumour stroma

What it is

Compound class
FAP-targeting peptide radioligand (DOTAGA-conjugated FAP-2286)
Target / mechanism
Fibroblast activation protein (FAP) PMID 40236533
Clinical application
Cancer (FAP-expressing tumors) diagnosis and therapy PMID 40236533
Theranostic pair
—

Published syntheses

No synthesis has been parsed for this agent yet.

Need this precursor?We can point you to suppliers for [111In]DOTAGA-FAP-2286, or handle the enquiry for you.

Get in touch

Notes

Added at stage 22: promoted from 'Reported once' (single-article, no diagnostic pair at discovery) because a full-text synthesis with extracted data exists in parsed-therapy.xlsx -- PMID(s): 40236533. Target/mechanism, clinical application, indications, approval and precursor fields still need per-agent research and are intentionally left empty. Compound class inferred from precursor name (not stated outright) -- PMID 40236533: 'We designed DOTAGA-FAP-2286 and DOTAGA-FAP-2286-ALB'.
Ask a question